(VIANEWS) – Shares of Inovio Pharmaceuticals (NASDAQ: INO) slid by a staggering 32.62% in 30 days from $2.79 to $1.88 at 13:33 EST on Friday, after two consecutive sessions in a row of gains. NASDAQ is falling 0.3% to $11,354.62, after two consecutive sessions in a row of gains.
Inovio Pharmaceuticals’s last close was $1.75, 83.06% under its 52-week high of $10.33.
Today’s last reported volume for Inovio Pharmaceuticals is 7403633 which is 29.25% above its average volume of 5727833.
Inovio Pharmaceuticals’s Sales
Inovio Pharmaceuticals’s sales growth is 138.1% for the ongoing quarter and a decline by 33% for the next. The company’s growth estimates for the present quarter is 17.9% and a drop 3.4% for the next.
Inovio Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth declined by 85%, now sitting on 1.77M for the twelve trailing months.
Inovio Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.89%, a negative 4.71%, and a positive 5.63%, respectively.
Inovio Pharmaceuticals’s highest amplitude of average volatility was 4.74% (last week), 8.40% (last month), and 5.63% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Inovio Pharmaceuticals’s stock is considered to be overbought (>=80).
Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value
Inovio Pharmaceuticals’s stock is valued at $1.88 at 13:33 EST, way under its 52-week high of $10.33 and way higher than its 52-week low of $1.60.
Inovio Pharmaceuticals’s Moving Average
Inovio Pharmaceuticals’s worth is way below its 50-day moving average of $3.03 and way below its 200-day moving average of $5.40.
More news about Inovio Pharmaceuticals (INO).